We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights include Halozyme Therapeutics, Avnet, BILL and Venture Global
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 15, 2026 – Stocks in this week’s article are Halozyme Therapeutics (HALO - Free Report) , Avnet, Inc. (AVT - Free Report) , BILL Holdings, Inc. (BILL - Free Report) and Venture Global, Inc. (VG - Free Report) .
4 Best PEG Value Stocks to Buy Now for Strong Growth & Returns
At a time when volatility strikes every second day, investors often rely on value investing rather than other options like growth or momentum. As soon as other investors start selling their stocks at a cheaper rate in times of market uncertainty, value investors take this as an opportunity to pick good stocks at a discounted price.
Several stocks that have surged significantly in the recent past have shown the overwhelming success of this pure-play investment strategy. Here, we discuss four such stocks — Halozyme Therapeutics, Avnet, Inc., BILL Holdings, Inc. and Venture Global, Inc..
However, this apparently simple value investment technique has some drawbacks and not understanding the strategy properly may often lead to "value traps." In such a situation, these value picks start to underperform over the long run as the temporary problems, which once drove the share price down, turn out to be persistent.
There are many value investment yardsticks, such as dividend yield, P/E or P/B, which are simple and can single out whether a stock is trading at a discount.
However, for investors looking to escape such value traps, it is also vital to determine where the stock would be headed in the next 12 to 24 months. Warren Buffett advises these investors to focus on the earnings growth potential of a stock. This is where lies the importance of a not-so-popular value investing metric, the PEG ratio.
PEG Ratio at a Glance
The PEG ratio is defined as (Price/ Earnings)/Earnings Growth Rate
A low PEG ratio is always better for value investors.
While P/E alone fails to identify a true value stock, PEG helps find the intrinsic value of a stock.
There are some drawbacks to using the PEG ratio. It doesn't consider the very common situation of changing growth rates, such as the forecast of the first three years at a very high growth rate, followed by a sustainable but lower growth rate over the long term.
Hence, PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.
Here are four stocks that qualified the screening:
Halozyme: It develops oncology treatments and licenses its ENHANZE drug-delivery technology, which enables subcutaneous formulations of medicines for partners including Roche, Takeda, J&J, AbbVie, Lilly and Bristol Myers. The company earns royalties and product revenues from partnered drugs using ENHANZE, which is based on its patented recombinant human hyaluronidase enzyme (rHuPH20).
Halozyme currently has a Zacks Rank #2 and a Value Score of B. HALO also has an impressive five-year expected growth rate of 32%.
Avnet: Phoenix, AZ-based Avnet is a global distributor of electronic components and computer products, serving OEMs, EMS providers, ODMs and resellers across more than 140 countries. Its two segments, Electronic Components and Farnell, distribute semiconductors and IP&E devices while providing supply-chain management, inventory replenishment, engineering design, integration and assembly services.
BILL: San Jose, CA-based BILL Holdings provides an AI-powered financial operations platform for small and midsize businesses, automating accounts payable, accounts receivable, payments, expenses, procurement and cash-flow forecasting. Its platform integrates accounting systems and serves a network of about 9.2 million members, with capabilities expanded through its Finmark, Divvy and Invoice2go acquisitions.
Apart from a discounted PEG and P/E, BILL currently has a Zacks Rank #1 and a Value Score of B. BILL has a long-term expected growth rate of 30%.
Venture Global: Based in Arlington, VA, Venture Global develops LNG export projects along the U.S. Gulf Coast and generates revenues through long-term sales agreements and spot LNG cargoes. Its Calcasieu Pass Project, featuring 18 modular liquefaction trains, began commercial operations in April 2025 and exported 38 cargoes in the first quarter of 2026.
VG has a Zacks Rank #1 and a Value Score of B. Venture Global also has an impressive five-year expected growth rate of 14.9%.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
View the Zacks #1 Rank List
Image: Bigstock
Zacks.com featured highlights include Halozyme Therapeutics, Avnet, BILL and Venture Global
For Immediate Release
Chicago, IL – September 15, 2026 – Stocks in this week’s article are Halozyme Therapeutics (HALO - Free Report) , Avnet, Inc. (AVT - Free Report) , BILL Holdings, Inc. (BILL - Free Report) and Venture Global, Inc. (VG - Free Report) .
4 Best PEG Value Stocks to Buy Now for Strong Growth & Returns
At a time when volatility strikes every second day, investors often rely on value investing rather than other options like growth or momentum. As soon as other investors start selling their stocks at a cheaper rate in times of market uncertainty, value investors take this as an opportunity to pick good stocks at a discounted price.
Several stocks that have surged significantly in the recent past have shown the overwhelming success of this pure-play investment strategy. Here, we discuss four such stocks — Halozyme Therapeutics, Avnet, Inc., BILL Holdings, Inc. and Venture Global, Inc..
However, this apparently simple value investment technique has some drawbacks and not understanding the strategy properly may often lead to "value traps." In such a situation, these value picks start to underperform over the long run as the temporary problems, which once drove the share price down, turn out to be persistent.
There are many value investment yardsticks, such as dividend yield, P/E or P/B, which are simple and can single out whether a stock is trading at a discount.
However, for investors looking to escape such value traps, it is also vital to determine where the stock would be headed in the next 12 to 24 months. Warren Buffett advises these investors to focus on the earnings growth potential of a stock. This is where lies the importance of a not-so-popular value investing metric, the PEG ratio.
PEG Ratio at a Glance
The PEG ratio is defined as (Price/ Earnings)/Earnings Growth Rate
A low PEG ratio is always better for value investors.
While P/E alone fails to identify a true value stock, PEG helps find the intrinsic value of a stock.
There are some drawbacks to using the PEG ratio. It doesn't consider the very common situation of changing growth rates, such as the forecast of the first three years at a very high growth rate, followed by a sustainable but lower growth rate over the long term.
Hence, PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.
Here are four stocks that qualified the screening:
Halozyme: It develops oncology treatments and licenses its ENHANZE drug-delivery technology, which enables subcutaneous formulations of medicines for partners including Roche, Takeda, J&J, AbbVie, Lilly and Bristol Myers. The company earns royalties and product revenues from partnered drugs using ENHANZE, which is based on its patented recombinant human hyaluronidase enzyme (rHuPH20).
Halozyme currently has a Zacks Rank #2 and a Value Score of B. HALO also has an impressive five-year expected growth rate of 32%.
Avnet: Phoenix, AZ-based Avnet is a global distributor of electronic components and computer products, serving OEMs, EMS providers, ODMs and resellers across more than 140 countries. Its two segments, Electronic Components and Farnell, distribute semiconductors and IP&E devices while providing supply-chain management, inventory replenishment, engineering design, integration and assembly services.
Avnet currently has a Zacks Rank #1 and a Value Score of B. AVT also has an impressive five-year expected growth rate of 31.3%. You can see the complete list of today's Zacks #1 Rank stocks here.
BILL: San Jose, CA-based BILL Holdings provides an AI-powered financial operations platform for small and midsize businesses, automating accounts payable, accounts receivable, payments, expenses, procurement and cash-flow forecasting. Its platform integrates accounting systems and serves a network of about 9.2 million members, with capabilities expanded through its Finmark, Divvy and Invoice2go acquisitions.
Apart from a discounted PEG and P/E, BILL currently has a Zacks Rank #1 and a Value Score of B. BILL has a long-term expected growth rate of 30%.
Venture Global: Based in Arlington, VA, Venture Global develops LNG export projects along the U.S. Gulf Coast and generates revenues through long-term sales agreements and spot LNG cargoes. Its Calcasieu Pass Project, featuring 18 modular liquefaction trains, began commercial operations in April 2025 and exported 38 cargoes in the first quarter of 2026.
VG has a Zacks Rank #1 and a Value Score of B. Venture Global also has an impressive five-year expected growth rate of 14.9%.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2989436/4-best-peg-value-stocks-to-buy-now-for-strong-growth-return
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.